Effects of a polypeptide drug—XMT on depression mouse models
CSTR:
Author:
Affiliation:

Department of Pharmaceutical Care,General Hospital of PLA,Department of Pharmaceutical Care,General Hospital of PLA,Department of Pharmaceutical Care,General Hospital of PLA,Department of Pharmaceutical Care,General Hospital of PLA,Faculty of Pharmacy,Bengbu Medical College

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To study the antidepressant effect of a polypeptide drugs—XMT. Methods Using the suspension test, forced swim test, 5-hydroxy-L-tryptophan (5-HTP) induced head twitch response test and yohimbine induced lethality test in mice, the antidepressant effect and the possible mechanisms of XMT were measured. Results In the tail suspension test, repeated administration (0.3-10 mg/kg, sc) with XMT for 5 d reduced the immobility time in mice (P<0.05 vs the normal saline control). XMT (0.3-5.0 mg/kg, sc for 5 d) can reduced the immobility time in the forced swim test in mice (P<0.05 vs the normal saline control), while there was no central stimulated effect during the effective doses (0.3-5.0 mg/kg). Furthermore, XMT in repeated doses (5.0 and 1.0 mg/kg, sc for 5 d) decreased the 5-HTP induced head twitch response in mice (P<0.01, P<0.05 vs the normal saline control), while it had no effect on the yohimbine toxicity (P>0.05 vs the normal saline control). Conclusion XMT has antidepressant effect which may be related to the property of inhibition the 5-HT2 receptor, etc.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 12,2014
  • Revised:May 08,2014
  • Adopted:May 19,2014
  • Online: May 24,2014
  • Published:
Article QR Code